Latest News & Updates of Loncom Pharma

Biocom Pharma will participate in CPHI China 2026 in Shanghai, showcasing APIs, FDFs, CDMO, technology transfer, and global registration services. The company invites global partners to visit Booth W6C12 to explore collaboration opportunities in development, manufacturing, and commercialization, strengthening long-term partnerships and accelerating pharmaceutical market access worldwide efforts worldwide.

Biocom participated in FCE Pharma 2026 in São Paulo, Brazil, strengthening connections with pharmaceutical partners across Latin America. Through discussions on registration, market access, supply chains, and quality systems, the company secured multiple cooperation opportunities, expanded its regional network, and reinforced its commitment to long-term growth in the Latin American market.

Biocom has been named among the "2026 China CRO Outstanding Brand Top 20" at the 92nd PHARMCHINA. The award recognizes the company’s full‑chain pharmaceutical R&D capabilities, steady business performance, and industry leadership. Learn more about Biocom’s commitment to innovating quality medicines for public health.

Biocom debuted at CPHI Japan 2026, connecting with Asian pharma leaders and showcasing APIs and intermediates. The event strengthened East Asian partnerships and confirmed Biocom’s adherence to ICH and global quality standards.